Benedikt von Braunmühl

home / authors / benedikt-von-braunm-hl

Articles

Enhancing CDMO Capabilities to Meet Evolving Client Needs

Benedikt von Braunmühl;Rentschler Biopharma

July 16th 2025

Rentschler Biopharma is evolving its CDMO capabilities through strategic partnerships, infrastructure investments, and sustainability initiatives to better support clients' complex biologics programs.

Latest Updated Articles

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

3D rendered laboratory test tubes with fluorescent green positive results in uv light | Image Credit: ©mguido - stock.adobe.com

Published: July 16th 2025 | Updated: July 17th 2025

Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation

Syringe aimed at the center of a target. Pharmacogenetics concept, symbolizing precise drug delivery based on genetic profiles. Low poly style | Image Credit: ©Елена Бутусова -stock.adobe.com

Published: July 4th 2025 | Updated: July 17th 2025

Modeling Approaches for Determination of Pharmacokinetics/Pharmacodynamics

Published: June 23rd 2025 | Updated: July 17th 2025

BIO 2025: Speeding Up Development of Next-Generation Biologics

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777